NCT00268476 2023-04-18
STAMPEDE
Medical Research Council
Phase 2/3 Active not recruiting
Clinical Trials
7 trialsNCT04488614 2020-07-30
PBCB
Helse Stavanger HF
Enrolling by invitation
NCT01006395 2019-07-05
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)
Austin Health
Phase 2/3 Completed
NCT01472146 2017-05-09
ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer
Instituto Nacional de Cancer, Brazil
Phase 2 Completed
NCT00489905 2013-10-23
Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Hospital Authority, Hong Kong
Phase NA Completed
NCT00691236 2011-06-23
ZOL
Tata Memorial Hospital
Phase 2/3 Unknown
NCT01234129 2010-11-04
Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
Instituto Mexicano del Seguro Social
Completed